Caricamento...
Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Osteosarcoma
BACKGROUND: Survival outcomes for patients with osteosarcoma have remained stagnant over the past three decades. Targeting of ganglioside GD2, a glycosphingolipid on the cell surface of some tumors, with immunotherapy has resulted in improved outcomes for patients with neuroblastoma. The expression...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946333/ https://ncbi.nlm.nih.gov/pubmed/24166473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28461 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|